{"filing":{"accession_number":"0001193125-26-296981","cik":"0001563577","ticker":"GRTX","company_name":"Galera Therapeutics, Inc.","form":"8-K","filing_date":"2026-07-07","report_date":null,"primary_document":"d135095d8k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1563577/000119312526296981/d135095d8k.htm"},"events":[{"id":16342,"run_id":14596,"accession_number":"0001193125-26-296981","anchor_item_number":"8.01","event_type":"other_material","event_domain":"catchall","is_material":true,"confidence":0.75,"summary":"The disclosure announces a 1:200 reverse stock split approved by the board and effective July 12, 2026. While reverse stock splits are capital structure events that affect share count and pricing, they do not fit neatly into the specific taxonomy categories (not M\u0026A, not a debt/equity issuance in the traditional sense, not a dividend, not a delisting notice). The event is material to investors as it materially alters the share structure and trading mechanics, but the domain is financial/capital structure rather than a named event type, warranting classification as other_material.","company_name":"Galera Therapeutics, Inc.","ticker":"GRTX","filing_date":"2026-07-07","form":"8-K","submitted_at":null,"items":[{"id":14416,"accession_number":"0001193125-26-296981","item_number":"8.01","item_title":null,"event_type":"other_material","event_domain":"catchall","is_material":true,"confidence":0.75,"reasoning":"The disclosure announces a 1:200 reverse stock split approved by the board and effective July 12, 2026. While reverse stock splits are capital structure events that affect share count and pricing, they do not fit neatly into the specific taxonomy categories (not M\u0026A, not a debt/equity issuance in the traditional sense, not a dividend, not a delisting notice). The event is material to investors as it materially alters the share structure and trading mechanics, but the domain is financial/capital structure rather than a named event type, warranting classification as other_material.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-07T19:17:55.182746+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":14416,"accession_number":"0001193125-26-296981","item_number":"8.01","item_title":null,"event_type":"other_material","event_domain":"catchall","is_material":true,"confidence":0.75,"reasoning":"The disclosure announces a 1:200 reverse stock split approved by the board and effective July 12, 2026. While reverse stock splits are capital structure events that affect share count and pricing, they do not fit neatly into the specific taxonomy categories (not M\u0026A, not a debt/equity issuance in the traditional sense, not a dividend, not a delisting notice). The event is material to investors as it materially alters the share structure and trading mechanics, but the domain is financial/capital structure rather than a named event type, warranting classification as other_material.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-07T19:17:55.182746+00:00","company_name":"Galera Therapeutics, Inc.","ticker":"GRTX","filing_date":"2026-07-07"}]}